FDA bans Dengvaxia
The Food and Drug Administration (FDA) has banned the sale and distribution of Dengvaxia.
This comes after the Paris-based manufacturer of the anti-dengue vaccine found that it can cause severe reactions to persons who have not contracted dengue.
The FDA has also ordered Sanofi in the Philippines to conduct an information campaign on the issue.
The agency is calling on health professionals and the public to help government gather information on the conditions of persons who have previously received shots of Dengvaxia.